Targeting of Immune Cells by Human Adenoviruses: CD46 Receptor Density Influences Entry of Chimaeric Ad5F35 into Natural Killer Cells
- 1Leeds Institute of Medical Research, School of Medicine, University of Leeds, Beckett Street, Leeds LS9 7TF, UK
- 2School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK
- 3Bioimaging Facility, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK
Abstract
Most adenovirus (Ad) vectors are based on the genome of human Ad type 5 (Ad5), which targets their entry to cells that express the Coxsackie and adenovirus receptor (CAR or CXADR). However, certain human Ads do not use CAR; for example, Ad35 interacts with cell surface CD46 and Ad3 uses desmoglein 2 (DSG2) for cell entry. In this study, a comparison of different Ad receptors using transcriptomic and proteomic databases showed that CD46 is widely expressed across human cells and tissues whereas CAR and DSG2 are more restricted to epithelial cells. We have used a hybrid virus, Ad5F35, that comprises an Ad5 genome in which the Ad5 fibre was replaced with that of Ad35, thus retargeting the virus from CAR- to CD46-expressing cells and enabling transduction of primary human NK and T cells. However, lymphocytes required approximately 10-to-20-fold-more Ad5F35 particles per cell (ppc) compared to A549 epithelial cells to achieve a similar level of transduction. Consistent with this, quantitation of the cell-surface density of CD46 molecules revealed approximately 100 CD46 molecules per µm2 in primary NK cells compared with approximately 2000 CD46 per µm2 in HeLa cells, a 20-fold difference. Cell surface CD46 density was reduced by approximately 95% by RNA interference in HeLa cells to levels that approximate those found on NK cells. Lower CD46 density reduced transduction by Ad5F35 but this could be compensated for with increased MOI. Our results identify the density of cell surface CD46 as a critical determinant of Ad5F35 transduction and demonstrate that Ad5F35 is an efficient vector for gene delivery in primary human NK cells.
Related
- Targeting microglial P2Y12-receptor signalling attenuates neurodegeneration in experimental Parkinsons disease
- Antibody 3CF5 neutralizes historical and emerging H5Nx influenza viruses by targeting a conserved non-receptor-binding hemagglutinin epitope
- High Temporal Resolution Imaging Reveals Endosomal Membrane Penetration and Escape of Adenoviruses in Real Time
- Modular Surface Engineering of Feline Parvovirus Virus-Like Particles for Antigen Presentation and Receptor-Mediated Cell Targeting
- Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade.
BibTeX
@article{barr2026targeting,
title = {{Targeting of Immune Cells by Human Adenoviruses: CD46 Receptor Density Influences Entry of Chimaeric Ad5F35 into Natural Killer Cells}},
author = {Tyler Barr and Elif Aktar and Sian L. Drake and Magdalena Karwatka and Erica B. Wilson and Ruth Hughes and G. Eric Blair and Graham P. Cook},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209183},
url = {https://www.mdpi.com/1422-0067/27/20/9183},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Targeting of Immune Cells by Human Adenoviruses: CD46 Receptor Density Influences Entry of Chimaeric Ad5F35 into Natural Killer Cells
AU - Tyler Barr
AU - Elif Aktar
AU - Sian L. Drake
AU - Magdalena Karwatka
AU - Erica B. Wilson
AU - Ruth Hughes
AU - G. Eric Blair
AU - Graham P. Cook
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209183
UR - https://www.mdpi.com/1422-0067/27/20/9183
AB - Most adenovirus (Ad) vectors are based on the genome of human Ad type 5 (Ad5), which targets their entry to cells that express the Coxsackie and adenovirus receptor (CAR or CXADR). However, certain human Ads do not use CAR; for example, Ad35 interacts with cell surface CD46 and Ad3 uses desmoglein 2 (DSG2) for cell entry. In this study, a comparison of different Ad receptors using transcriptomic and proteomic databases showed that CD46 is widely expressed across human cells and tissues whereas CAR and DSG2 are more restricted to epithelial cells. We have used a hybrid virus, Ad5F35, that comprises an Ad5 genome in which the Ad5 fibre was replaced with that of Ad35, thus retargeting the virus from CAR- to CD46-expressing cells and enabling transduction of primary human NK and T cells. However, lymphocytes required approximately 10-to-20-fold-more Ad5F35 particles per cell (ppc) compared to A549 epithelial cells to achieve a similar level of transduction. Consistent with this, quantitation of the cell-surface density of CD46 molecules revealed approximately 100 CD46 molecules per µm2 in primary NK cells compared with approximately 2000 CD46 per µm2 in HeLa cells, a 20-fold difference. Cell surface CD46 density was reduced by approximately 95% by RNA interference in HeLa cells to levels that approximate those found on NK cells. Lower CD46 density reduced transduction by Ad5F35 but this could be compensated for with increased MOI. Our results identify the density of cell surface CD46 as a critical determinant of Ad5F35 transduction and demonstrate that Ad5F35 is an efficient vector for gene delivery in primary human NK cells.
SN - 1422-0067
ER -